A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

NCT07220954 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: AZD6234 Formulation 1
DRUG: AZD6234 Formulation 2 (low concentration)
DRUG: AZD6234 Formulation 2 (high concentration)
DRUG: AZD6234 Formulation 3

Sponsor

AstraZeneca

Collaborators

[object Object]